ClearBridge Mid Cap Strategy outperformed its Russell Midcap Index during the third quarter, driven by standout stock ...
Saguaro Biosciences, a pioneer in non-toxic live cell reagents for enhanced drug insights, announces a new distribution ...
Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, November 5, 2025, at 8:00 a.m. CST to review its first quarter fiscal 2026 ...
Bio-Techne will release its first-quarter earnings soon, and analysts anticipate the bottom line to remain unchanged year ...
TipRanks on MSN
Bio-Techne price target raised to $70 from $65 at TD Cowen
TD Cowen analyst Kyle Boucher raised the firm’s price target on Bio-Techne (TECH) to $70 from $65 and keeps a Buy rating on the shares. The firm ...
ConMed Corp. (NYSE: CNMD), a surgical-device maker originally based in the Mohawk Valley region, recently announced that Kim ...
Ratings for Bio-Techne (NASDAQ: TECH) were provided by 5 analysts in the past three months, showcasing a mix of bullish and ...
Shares of Bio-Techne Corp. shed 4.43% to $59.18 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.38% to 6,714.59 and Dow Jones ...
This year’s A-List shows that the revenues for the top five public companies in spatial biology have risen nine percent from a year ago ...
Among others, the following stocks were impacted: Bio-Techne’s shares are very volatile and have had 21 moves greater than 5% ...
Arab Finance: Hossam Heiba, CEO of the General Authority for Investment and Free Zones (GAFI), unveiled plans for a new initiative to allow startups access to new foreign markets and provide better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results